ReviewInternational journal of nanomedicine2026
Reactive Oxygen Species-Regulating Nanoengineered Hydrogels for Bone Regeneration: A Mechanism-Based Framework of Responsive Delivery, Intrinsic Scavenging, Nanozyme Catalysis, and Osteoimmunomodulation.
Review in International journal of nanomedicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Bone regeneration is frequently impaired by excessive reactive oxygen species (ROS). Persistent oxidative stress disrupts mitochondrial function, sustains inflammation, and suppresses osteogenic differentiation. Nanoengineered hydrogels provide versatile platforms for local microenvironment remodeling. This review summarizes recent advances in ROS-regulating nanoengineered hydrogels for bone regeneration, with emphasis on redox microenvironment remodeling and osteoimmunomodulation. ROS-responsive hydrogels exploit pathological oxidants as endogenous triggers for on-demand release of small molecules, proteins, neuropeptides, ions, and nanocomposites. Intrinsic ROS-scavenging hydrogels directly attenuate oxidative injury through redox-active polymers, polyphenols, nanomaterials, metal-ion chelation, and oxygen-regulating components. Nanozyme-integrated hydrogels provide catalytic functions that regulate superoxide, hydrogen peroxide, glucose metabolism, oxygen availability, and mitochondrial oxidative stress. ROS-regulated osteoimmunomodulatory hydrogels reshape immune-bone crosstalk by promoting pro-regenerative macrophage functions, suppressing excessive osteoclastogenesis, controlling infection-associated inflammation, and enhancing angiogenic and osteogenic signaling. Remaining challenges include defining disease-specific therapeutic redox windows, establishing standardized mechanistic and safety assessments, and improving long-term nanoengineered-component biocompatibility. Future development of personalized hydrogel systems may accelerate translation toward precision bone-regenerative therapy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.